» Authors » Jia V Li

Jia V Li

Explore the profile of Jia V Li including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 91
Citations 3164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Glymenaki M, Curio S, Shrestha S, Zhong Q, Rushton L, Barry R, et al.
Microbiome . 2025 Feb; 13(1):60. PMID: 40022152
Background: Fecal abundances of Enterobacteriaceae and Enterococcaceae are elevated in patients following Roux-en-Y gastric bypass (RYGB) surgery. Concurrently, fecal concentrations of tyramine, derived from gut bacterial metabolism of tyrosine and/or...
2.
Balarajah S, Martinez-Gili L, Alexander J, Mullish B, Perry R, Li J, et al.
J Crohns Colitis . 2024 Dec; 19(1. PMID: 39657589
Background: Studies in the UK and North America have suggested a distinct disease profile in South Asians compared to that of White populations. Disparities in the medical and surgical management...
3.
Sangermani M, Desiati I, Jorgensen S, Li J, Andreassen T, Bathen T, et al.
Gut Microbes . 2024 Nov; 16(1):2427878. PMID: 39533520
An extensive network of microbial-host interactions exists in the gut, making the gut microbiome a complex ecosystem to untangle. The microbial composition and the fecal metabolites are important readouts to...
4.
Valdivia-Garcia M, Bi Y, Abaakil K, Li J
J Pharm Biomed Anal . 2024 Sep; 252:116480. PMID: 39326376
Trimethylamine (TMA) and trimethylamine-N-oxide (TMAO) play a crucial role in many biochemical processes within diverse organisms including animals, plants, fungi and bacteria. Studies have linked these metabolites with cardiovascular and...
5.
McGlone E, Hope D, Davies I, Dore M, Goldin R, Jones B, et al.
Biomed Pharmacother . 2024 Jun; 176:116888. PMID: 38861859
Objectives: Co-agonists at the glucagon-like peptide-1 and glucagon receptors (GLP1R/GCGR) show promise as treatments for metabolic dysfunction-associated steatotic liver disease (MASLD). Although most co-agonists to date have been heavily GLP1R-biased,...
6.
Liu J, Macnaughtan J, Kerbert A, Portlock T, Martinez Gonzalez J, Jin Y, et al.
Gut . 2024 Apr; 73(7):1183-1198. PMID: 38621924
Objective: Targeting bacterial translocation in cirrhosis is limited to antibiotics with risk of antimicrobial resistance. This study explored the therapeutic potential of a non-absorbable, gut-restricted, engineered carbon bead adsorbent, Yaq-001...
7.
Kiosia A, Dagbasi A, Berkley J, Wilding J, Prendergast A, Li J, et al.
Nutr Bull . 2024 Apr; 49(2):132-145. PMID: 38576109
The 'double burden of malnutrition' is a global health challenge that increasingly affects populations in both low- and middle-income countries (LMICs). This phenomenon refers to the coexistence of undernutrition and...
8.
Hartman T, Christie J, Wilson A, Ziegler T, Methe B, Flanders W, et al.
BMJ Open . 2024 Feb; 14(2):e081379. PMID: 38316601
Introduction: Recently published studies support the beneficial effects of consuming fibre-rich legumes, such as cooked dry beans, to improve metabolic health and reduce cancer risk. In participants with overweight/obesity and...
9.
Wang M, Guo J, Hart A, Li J
J Inflamm Res . 2023 Dec; 16:5845-5864. PMID: 38084103
Purpose: Indole-3-aldehyde (IAld) has been shown to improve intestinal epithelial barrier (IEB) function through the aryl hydrocarbon receptor (AhR) in murine colitis models. However, the impact of IAld on intestinal...
10.
Alotaibi A, Li J, Gooderham N
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765584
Colorectal cancer is driven by genetic and epigenetic changes in cells to confer phenotypes that promote metastatic transformation and development. Tumour necrosis factor-alpha (TNF-α), a pro-inflammatory mediator, regulates cellular communication...